Learn more

APARIN PETR GENNADIEVICH

Overview
  • Total Patents
    16
  • GoodIP Patent Rank
    229,139
  • Filing trend
    ⇩ 100.0%
About

APARIN PETR GENNADIEVICH has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are MSD WELLCOME TRUST HILLEMAN LABS PVT LTD, MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD and MSD WELLCOME TRUST HILLEMAN LAB PVT LTD.

Patent filings per year

Chart showing APARIN PETR GENNADIEVICHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Golovina Marina Eduardovna 15
#2 Lvov Vyacheslav Leonidovich 14
#3 Elkina Stanislava Ivanovna 14
#4 Aparin Petr Gennadievich 14
#5 Shmigol Vladimir Igorevich 10
#6 Ledov Vladimir Alekseyevich 5
#7 Markina Anna Aleksandrovna 5
#8 Shekht Maria Evgen Evna 3
#9 Elkina Stanislava Ivanovan 1
#10 Markina Anna Alexandrovna 1

Latest patents

Publication Filing date Title
US2018043004A1 Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
KR20160029060A Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
US2014037687A1 Exopolysaccharide of Shigella sonnei bacteria, method for producing same, vaccine and phamaceutical composition containing same
EA030920B1 Exopolysaccharide of shigella sonnei bacteria, method for producing same, vaccine and pharmaceutical composition containing same
WO2004003215A1 Method of isolating biologically active fraction containing clinically acceptable native slipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides